<?xml version="1.0" encoding="UTF-8"?>
<p>Despite not being particularly lethal, SARS‐CoV‐2 is very contagious. In a published clinical cohort of patients with COVID‐19, they observed that acute cardiac injury, shock, and arrhythmias were present in 7.2%, 8.7%, and 16.7% of patients, respectively, with higher prevalence amongst patients requiring intensive care.
 <xref rid="jce14479-bib-0002" ref-type="ref">
  <sup>2</sup>
 </xref> In this report, myocardial injury biomarkers levels were significantly higher in patients requiring ICU admission than in those not treated in the ICU (median creatine kinase‐MB level 18 U/l vs 14 U/l; 
 <italic>P</italic> &lt; .001; and high‐sensitivity cardiac troponin I [hs‐cTnI] level 11.0 pg/mL vs 5.1 pg/mL; 
 <italic>P</italic> = .004), suggesting that patients with severe symptoms often have complications involving acute myocardial injury.
 <xref rid="jce14479-bib-0002" ref-type="ref">
  <sup>2</sup>
 </xref> Overall, arrhythmia rate was also more frequent in ICU patients (44.4% vs 6.9%; 
 <italic>P</italic> &lt; .001). Despite the relevance of these initial data, the authors did not provide any arrhythmia classification or definition Table 
 <xref rid="jce14479-tbl-0001" ref-type="table">1</xref>.
</p>
